Cboe Global Markets, Inc.
Congress has disclosed 13 buys and 7 sells of CBOE (Cboe Global Markets, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying CBOE and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Jefferson Shreve | 2025-04-07 | $205.19 | $335.53 | +63.5% | in profit |
| John Boozman | 2025-04-08 | $206.04 | $335.53 | +62.8% | in profit |
| Gilbert Cisneros | 2025-11-12 | $258.97 | $335.53 | +29.6% | in profit |
| Alan Armstrong | 2026-03-27 | $271.67 | $335.53 | +23.5% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Finance. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
Legislation Related Legislation
Recent bills in this stock's sector (Finance). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10820 | Epstein Wall Street Records Act of 2026 | Finance and Financial Sector | 2026-10-15 |
| HR 10821 | To amend the Federal Deposit Insurance Act to make changes to the Standard Maximum Deposit Insurance Amount, and for other purposes. | Finance and Financial Sector | 2026-10-15 |
| S 4395 | Terrorism Risk Insurance Program Reauthorization Act of 2026 | Finance and Financial Sector | 2026-10-05 |
| S 1564 | Floodplain Enhancement and Recovery Act | Finance and Financial Sector | 2026-10-05 |
| S 5644 | A bill to amend title 31, United States Code, to exempt transactions with respect to cash reward payments by crime stopper organizations from certain currency transaction reports. | Finance and Financial Sector | 2026-09-30 |
21 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| John Boozman | Senate | OTHER | Joint | 2026-07-31 | 17 days | -4.9% | $1K–$15K | 60.6 | ↗ eFD |
| Alan Armstrong | Senate | BUY ◆ insider divergence · moderate | Self | 2026-03-27 | 116 days | +0.7% | $1K–$15K | 82.9 | ↗ eFD |
| Gilbert Cisneros | House | SELL | Self · 150 Main Street Trust > Bank of America | 2025-12-19 | 21 days | +5.5% | $1K–$15K 0.1% of NW |
1.1 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2025-11-12 | 30 days | -3.0% | $1K–$15K 0.1% of NW |
5.0 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence | Self · CRT - Standard Unit Trust | 2025-05-12 | 3 days | -0.9% | $50K–$100K <0.1% of NW |
29.7 | ↗ filing |
| John Boozman | Senate | BUY ◆ insider divergence · moderate | Joint | 2025-04-08 | 499 days | +42.4% | $1K–$15K | 86.9 | ↗ eFD |
| Jefferson Shreve | House | BUY ◆ insider divergence · moderate | Self · CRT - Standard Unit Trust | 2025-04-07 | 18 days | +3.0% | $15K–$50K <0.1% of NW |
33.7 | ↗ filing |
| Jefferson Shreve | House | BUY ◆ insider divergence · moderate | Self · CRT - Standard Unit Trust | 2025-03-13 | 15 days | +3.5% | $15K–$50K <0.1% of NW |
53.7 | ↗ filing |
| Jefferson Shreve | House | BUY ◆ insider divergence · moderate | Self · CRT - Standard Unit Trust | 2025-03-05 | 23 days | +4.9% | $15K–$50K <0.1% of NW |
69.2 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X142 | 2023-09-08 | 28 days | — | $1K–$15K 0.3% of NW |
10.6 | ↗ filing |
| Lois Frankel | House | SELL | Self · Morgan Stanley IRA - X142 | 2022-07-22 | 39 days | — | $1K–$15K 0.3% of NW |
15.7 | ↗ filing |
| Raúl Grijalva | House | SELL | Spouse | 2021-12-17 | 3 days | — | $1K–$15K | 40.5 | ↗ filing |
| Raúl Grijalva | House | BUY | Spouse | 2021-11-24 | 21 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2021-03-01 | 0 days | — | $1K–$15K 0.3% of NW |
22.3 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2021-02-19 | 0 days | — | $1K–$15K 0.3% of NW |
40.5 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2021-02-18 | 0 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-11-03 | 0 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2020-09-16 | 27 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-04-29 | 9 days | — | $1K–$15K 0.1% of NW |
40.5 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-04-16 | 22 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Thomas MacArthur | House | SELL | Joint | 2015-08-19 | 13 days | — | $15K–$50K | 90.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in CBOE — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in CBOE, 2 coincided with corporate insiders moving the same way within 60 days, and 5 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-08-12 | Froetscher Janet P | Director | SELL 10b5-1 | $261K | ↗ EDGAR |
| 2026-05-18 | Froetscher Janet P | Director | SELL 10b5-1 | $438K | ↗ EDGAR |
| 2026-02-23 | Wilkinson Allen | C-suite | SELL | $73K | ↗ EDGAR |
| 2026-02-18 | Fitzpatrick Edward J. | Director | SELL | $1.1M | ↗ EDGAR |
| 2026-02-18 | Matturri Alexander JR | Director | SELL | $428K | ↗ EDGAR |
| 2025-09-02 | Isaacson Christopher A | C-suite | SELL 10b5-1 | $1.2M | ↗ EDGAR |
| 2025-06-09 | Isaacson Christopher A | C-suite | SELL 10b5-1 | $1.1M | ↗ EDGAR |
| 2025-05-23 | Clay Catherine R | Other | SELL 10b5-1 | $815K | ↗ EDGAR |
| 2025-03-13 | Goodman Jill R | Director | SELL | $292K | ↗ EDGAR |
| 2025-03-12 | Goodman Jill R | Director | SELL | $268K | ↗ EDGAR |
| 2025-02-24 | Wilkinson Allen | C-suite | SELL | $48K | ↗ EDGAR |
| 2025-02-20 | Howson Dave | C-suite | SELL 10b5-1 | $78K | ↗ EDGAR |
| 2025-02-20 | Howson Dave | C-suite | SELL 10b5-1 | $750K | ↗ EDGAR |
| 2025-02-20 | Howson Dave | C-suite | SELL 10b5-1 | $353K | ↗ EDGAR |
| 2025-02-20 | Inzirillo Adam | Other | SELL | $42K | ↗ EDGAR |
| 2025-02-12 | Howson Dave | C-suite | SELL 10b5-1 | $2.3M | ↗ EDGAR |
| 2025-02-10 | Inzirillo Adam | Other | SELL | $17K | ↗ EDGAR |
| 2025-02-10 | Clay Catherine R | Other | SELL | $636K | ↗ EDGAR |
| 2024-12-13 | Inzirillo Adam | Other | SELL | $5K | ↗ EDGAR |
| 2024-09-04 | Griebenow Jill | C-suite | SELL 10b5-1 | $346K | ↗ EDGAR |
| 2024-09-03 | Isaacson Christopher A | C-suite | SELL 10b5-1 | $1.2M | ↗ EDGAR |
| 2024-08-26 | Wilkinson Allen | C-suite | SELL | $16K | ↗ EDGAR |
| 2024-08-22 | McPeek Jennifer J | Director | SELL | $412K | ↗ EDGAR |
| 2024-08-07 | Clay Catherine R | Other | SELL | $95K | ↗ EDGAR |
| 2024-08-07 | Clay Catherine R | Other | SELL | $27K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-08-12 | Froetscher Janet P Director 10b5-1 | SELL | $261K |
| Congress | 2026-07-31 | John Boozman | OTHER | $1K–$15K |
| ◆ insider | 2026-05-18 | Froetscher Janet P Director 10b5-1 | SELL | $438K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| ◆ insider | 2026-02-23 | Wilkinson Allen C-suite | SELL | $73K |
| ◆ insider | 2026-02-18 | Fitzpatrick Edward J. Director | SELL | $1.1M |
| ◆ insider | 2026-02-18 | Matturri Alexander JR Director | SELL | $428K |
| Congress | 2025-12-19 | Gilbert Cisneros | SELL | $1K–$15K |
| Congress | 2025-11-12 | Gilbert Cisneros | BUY | $1K–$15K |
| ◆ insider | 2025-09-02 | Isaacson Christopher A C-suite 10b5-1 | SELL | $1.2M |
| ◆ insider | 2025-06-09 | Isaacson Christopher A C-suite 10b5-1 | SELL | $1.1M |
| ◆ insider | 2025-05-23 | Clay Catherine R Other 10b5-1 | SELL | $815K |
| Congress | 2025-05-12 | Jefferson Shreve | SELL | $50K–$100K |
| Congress | 2025-04-08 | John Boozman | BUY | $1K–$15K |
| Congress | 2025-04-07 | Jefferson Shreve | BUY | $15K–$50K |
| Congress | 2025-03-13 | Jefferson Shreve | BUY | $15K–$50K |
| ◆ insider | 2025-03-13 | Goodman Jill R Director | SELL | $292K |
| ◆ insider | 2025-03-12 | Goodman Jill R Director | SELL | $268K |
| Congress | 2025-03-05 | Jefferson Shreve | BUY | $15K–$50K |
| ◆ insider | 2025-02-24 | Wilkinson Allen C-suite | SELL | $48K |
| ◆ insider | 2025-02-20 | Howson Dave C-suite 10b5-1 | SELL | $78K |
| ◆ insider | 2025-02-20 | Howson Dave C-suite 10b5-1 | SELL | $750K |
| ◆ insider | 2025-02-20 | Howson Dave C-suite 10b5-1 | SELL | $353K |
| ◆ insider | 2025-02-20 | Inzirillo Adam Other | SELL | $42K |
FAQ Common questions
How much has Congress traded CBOE?
13 disclosed buys and 7 sells of CBOE (Cboe Global Markets, Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade CBOE?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.